Electrocardiogram health pharma IMage credit pixabay/GDJInfor has announced a global strategic partnership with HARMAN International, a wholly-owned subsidiary of Samsung Electronics Co Ltd. While HARMAN is best known for its connected car technology, its Digital Transformation Solutions (DTS), through HARMAN Life-ware is transforming healthcare and life sciences industries with new technologies.

Its healthcare solutions include:

  • Digital Therapeutics
  • Virtual care and Remote Patient Monitoring
  • Connected Fitness
  • Unified Patient Engagement and Gamification
  • Care Solutions Modernization
  • Care Analytics

DTS and Infor will jointly develop an integrated healthcare solution. It will help clients seamlessly transform data, analytics, intelligence, and governance functions in a secure, cost-effective, and privacy-preserving manner. The combination of HARMAN technology and Infor Software offers huge opportunities for both.

David Owens, senior vice president, Digital Transformation Solutions at HARMAN, commented, “We are confident the partnership will help our clients streamline data and deliver insights that can improve patient and clinical outcomes for operational efficiency and effectiveness.

“Output from the HARMAN Intelligent Healthcare Platform and Infor Cloverleaf® Integration Suite output will be integrated back into existing applications and workflows to effect positive change within the healthcare environment. By working with esteemed partners like Infor, HARMAN can deliver business impact through integrated, creative connected solutions.”

What the new platform might deliver

Infor Cloverleaf with Infor Cloverleaf, the HARMAN Intelligent Healthcare Platform (IHP) with Infor Cloverleaf will give HARMAN greater access to data, both structured and unstructured.  It can then parse that data through the Data Machine, its Analytics and Visualisation engines and governance machine before moving insights and outputs out to external systems and partners with Infor Cloverleaf.

The increase in data access enables the HARMAN artificial intelligence and machine learning (AI/ML) algorithms to securely gain access to structured and unstructured data extracted from databases, interface engines, and CDA XML (clinical document architecture extensible markup language) documents.

Once analysed, the HARMAN IHP output can be passed back into existing healthcare provider systems such as ERP and EHR (electronic health records). The use cases are huge, with better insights into readmission predictions, attrition risk, the ability to predict and detect fraudulent claims and enhancing intelligent document processing.

The ability to analyse unstructured data could mean the video monitoring of patients. It can trigger alerts so the system can monitor multiple patients simultaneously, alerting the relevant healthcare staff when action is needed. Visual cues such as these can provide information beyond what vital signals show.

The combination will enable pharmaceutical, life sciences, and biotechnology organizations to collect and process more data relating to clinical trials. Monitoring systems can pick up changes that subjects may be unaware of, which means side effects are more accurately tracked. The data and insights collected can be passed back seamlessly into other systems for collation and review.

It can also use the HARMAN IHP and Infor Cloverleaf Integration Suite to process real-world evidence data critical to clinical trials management. One key benefit of the HARMAN IHP integration with the Infor Cloverleaf Integration Suite is that all output can be seamlessly integrated into existing applications and workflows.

Jeff Mueller, Infor vice president
Jeff Mueller, Infor vice president

Jeff Mueller, Infor vice president, commented, “Healthcare organizations face continued pressure to operate faster and more efficiently, while simultaneously needing to find new and innovative ways to digest and interpret data to create better patient outcomes.

“It’s paramount that healthcare organizations manage information, maintain confidentiality, integrity, privacy, and security, uphold high levels of encryption, and then make that data available in digestible formats. This would be impossible without modern technology solutions.

“This new partnership is all about healthcare innovation: Infor’s wealth of industry knowledge and perspective plus HARMAN’s acumen and reputation for developing cutting-edge technology.”

Enterprise Times: What does this mean

This is an exciting partnership that could offer major efficiencies in an industry that is struggling to fill positions across the world. While combining the HARMAN intelligent healthcare platform and Cloverleaf offers much potential, will Infor take it further with its other Healthcare solutions?

Once the work is complete, what will be interesting are the use cases that healthcare providers can demonstrate. That is where this partnership will show its value to HARMAN, Infor and the healthcare industry.


Please enter your comment!
Please enter your name here